Skip to content

UK Pregnancies Better Eating and Activity Trial

Improving pregnancy outcome in obese women; a multicentre randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN89971375
Enrollment
1546
Registered
2008-11-28
Start date
2009-11-01
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity during pregnancy Nutritional, Metabolic, Endocrine Obesity

Interventions

Current interventions as of 0/06/2012: The intervention is delivered by a health trainer in weekly sessions between 20 and 28 weeks' gestation and focusses on changing the diet (lowering the glycemic

Sponsors

King's College London (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Willing and able to give informed consent 2. Pregnant women with booking body mass index (BMI) greater than or equal to 30 kg/m^2 3. Singleton pregnancy

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 06/06/2012: 1. Unwilling or unable to give informed consent 2. Pregnant women with booking BMI less than 30 kg/m^2 3. Multiple pregnancy 4. Pre-existing diabetes mellitus 5. Pre-existing hypertension requiring treatment, pre-existing thyroid and renal disease, current psychosis, sickle cell disease, thalassemia, coeliac disease Previous exclusion criteria: 1. Unwilling or unable to give informed consent 2. Pregnant women with booking BMI less than 30 kg/m^2 3. Multiple pregnancy 4. Pre-existing diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Current primary outcome measure(s): 1. Maternal: GDM by HAPO criteria. 2. Infant: macrosomia (>90th customised birthweight centile). Previous primary outcome measure(s): Improved maternal glucose sensitivity, assessed at recruitment (10 - 16 weeks), and again in the third trimester (32 - 36 weeks).

Secondary

MeasureTime frame
Current secondary outcome measure(s): 1. Maternal: complications in pregnancy (inc GDM, pre-eclampsia, depression, quality of life), physical activity, diet, gestational weight gain, maternal body composition (skin folds), mode of delivery, hospital admissions. Health economic assessment. 2. Infant: adverse outcomes, neonatal unit admissions, SGA, LGA, body composition (skin folds). 3. At 6 months post partum: maternal and child diet and physical activity. Maternal general health (inc depression, quality of life). Maternal and child body composition. Childhood modifiers/modulators of obesity. 4. 3 years: To be confirmed; measures of maternal and child body composition, diet, physical activity. Childhood mental health, cardiovascular function. Previous secondary outcome measure(s): Reduction in foetal, maternal and pregnancy complications, assessed at recruitment (10 - 16 weeks), and again in the third trimester (32 - 36 weeks).

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026